Anemie je přítomna u více než 40 % pacientů s chronickým srdečním selháním, zvláště u těch se sníženou ejekční frakcí; příčina této souvislosti dosud není známa. Hematokrit se významným způsobem podílí na viskozitě plné krve, která do velké míry ovlivňuje celkovou periferní rezistenci, jež musí srdce překonávat. Snížení viskozity krve by tedy mohlo zmenšit dotížení selhávajícího srdce. Pro pacienty s homozygotní familiární hypercholesterolemií (HFH) jsou charakteristické výrazně zvýšené hodnoty cholesterolu lipoproteinů o nízké hustotě (LDL) a předčasný rozvoj ischemické choroby srdeční. Doporučený způsob léčby tohoto onemocnění představuje selektivní aferéza LDL cholesterolu u pacientů s HFH k odstranění LDL z krevního oběhu; současně bylo prokázáno, že se tak snižuje viskozita plné krve. Koncentrace natriuretického peptidu typu B (BNP) ukazují plnicí tlaky srdce a jsou ovlivňovány převážně dotížením. Hodnota BNP byla měřena u čtyř po sobě následujících pacientů s HFH před léčbou selektivní LDL aferézou a po ní. Zjistili jsme, že 20% snížení viskozity krve těchto pacientů LDL aferézou vedlo ke snížení hodnot BNP o 40 %. U pacientů s chronickým srdečním selháním by anemie mohla představovat kompenzační mechanismus organismu snižující dotížení selhávajícího srdce snížením viskozity krve.
Introduction
In approximately half of the patients with chronic heart failure, especially in those with reduced ejection fraction, normocytic anemia is present [1, 2] . Most studies have shown an inverse linear relationship between hematocrit or hemoglobin levels and survival: the SOLVD trial (Studies of Left Ventricular Dysfunction) reported a 2.7% increase in the adjusted risk of death per 1% reduction in hematocrit and the PRAISE (Prospective Randomized Amlodipine Survival Evaluation) trial described a 3% increase in risk for each 1% decline in hematocrit [3, 4] . The etiology is not yet understood. Several clinical trials have been performed in recent years with erythropoietin or other erythropoiesis stimulating drugs in order to reduce anemia in CHF patients, but until now these studies have failed to show improved cardiovascular outcome [5, 6] . A clear explanation why treatment of anemia in patients with congestive heart failure (CHF) does not improve cardiovascular prognosis has not yet been found. We and others [7, 8] hypothesized that an increase of the hematocrit-level in CHF patients will raise blood viscosity, which according to Poisseuille's Law enhances the peripheral resistance, against which the failing heart has to work. According to the law of Poisseuille (Q = ((ΔP· ·r 4 )/8·l) × 1/ ), in which represents blood viscosity, cardiac after--load has a vascular and a viscous component and blood fl ow will be enhanced by reducing its viscosity. Therefore, anemia in CHF patients might be a physiological adaptation mechanism to reduce workload for the failing heart.
Homozygous familial hypercholesterolemia (HFH) is a rare inborn error of metabolism caused by mutations in both alleles encoding for the LDL-receptor. The majority of these patients die untreated before the age of 20 yrs of ischemic heart disease as a result of markedly increased LDL-cholesterol levels; ischemic heart disease is refl ected in diastolic and/or systolic dysfunction. Since drug treatment is not always possible or insuffi cient to lower LDL-cholesterol, LDL can be removed extra-corporally by plasmapheresis or preferably by selective LDL-apheresis [9] [10] [11] . Earlier studies have demonstrated, that LDL apheresis in these patients reduces whole blood viscosity signifi cantly and this effect has been attributed to the reduction in acute phase proteins (fi brinogen and CRP) and the effects of LDL-lowering itself [12] .
Aim of our study is to determine the infl uence of lowering blood viscosity by selective LDL-apheresis on cardiac after-load in patients with homozygous familial hypercholesterolemia by comparing the level of B-type Natriuretic Peptide (BNP) before and after LDL-apheresis; BNP has been shown to be predominantly infl uenced by cardiac after-load [13] . This conceptual approach in patients with premature cardiac dysfunction might give physiological insight in why occurrence of anemia could be considered a physiological adaptation mechanism in CHF patients.
Patients and methods
After obtaining written informed consent and being in accordance with The Helsinki Declaration, a pilot-study was performed in 4 consecutive patients with homozygous familial hypercholesterolemia. They underwent cardiac investigations during 2 consecutive treatments with LDL-apheresis. In Table 1 the clinical history, medication and laboratory investigations at baseline are depicted for each individual patient. All patients also underwent transthoracic Doppler-echocardiography (TTE) at baseline. Further determination of cardiac hemodynamics consisted of measurement of BNP-levels immediately before and after LDL-apheresis, as well as simultaneous measure- Lower blood viscosity reduces cardiac after-load ment of blood pressure and heart frequency. Laboratory investigations before and after LDL-apheresis consisted of: hematocrit, fi brinogen and hs-CRP. Whole blood viscosity was measured within 30 minutes after withdrawal of blood at different shear rates (0.87, 1.182, 1.607, 2.19 and 4.04 s -1 ) with the Contraves LS 30, which is considered to be the standard for measurement of whole blood viscosity at low shear rate [14] . All cardiac investigations and blood withdrawals were done while the patient was in supine position. Two and a half hours after LDL-apheresis blood was withdrawn again for determination of hematocrit, BNP and whole blood viscosity. The Student t-test was used to test whether the relative changes from baseline were signifi cant. P-values < 0.05 were considered statistically signifi cant.
Results
In Table 1 the baseline characteristics of the patients are demonstrated. Only patient 4 revealed signifi cant reduction of systolic LV-function on transthoracic Doppler--echocardiography. Table 2 depicts measurement results of blood viscosity, BNP and LDL-cholesterol before and 0.5 and 2.5 h after LDL-apheresis, respectively. Finally, in Table 3 , the relative change from baseline is depicted for blood viscosity, BNP and LDL-cholesterol immediately after LDL-apheresis and after 2.5 h. Heart rate, blood pressure as well as hematocrit remained constant before and after LDL-apheresis.
Discussion
The signifi cant reduction of BNP-level by lowering blood viscosity with selective LDL-apheresis in these HFH patients demonstrates the important effect of blood viscosity on cardiac after-load.
During the last three decades, the biological role and potential clinical application of the natriuretic peptides as refl ection of increased intra-cardiac pressure in chronic heart failure have been extensively investigated [15] . Toischer et al. [13] showed that BNP is predominantly induced by afterload, which made it a good measurement parameter for our study, in which afterload according to Poisseuille's Law is being changed by lowering blood viscosity. The importance of blood viscosity for cardiac after--load has been shown in earlier studies, in which the role of blood viscosity has been demonstrated in the pathophysiology of hypertension and left ventricular hypertrophy [16, 17] . Animal studies showed that in normal or incipient failing hearts almost all BNP is produced in the atria [18] . This might be true for our patients as well; the decrease of fi lling pressures in the atria can be explained by the lower blood viscosity, which will have more impact in the atria than in the ventricles because of the lower shear rates in the atria. In our limited study, the relative reduction of BNP was higher than the relative reduction of whole blood viscosity. Blood is a non-Newtonian fl uid, which means that its viscosity changes when the shear rate varies. At lower shear rates blood viscosity shows a steep rise (Figure 1 ). In chronic heart failure low fl ow state exists, which will enhance the role of blood viscosity in this clinical situation. This may also explain, why reduction in BNP-level in our patients was more evident, when baseline BNP-level was higher The reduction of BNP-level is not due to elimination of this peptide itself by the apheresis, because after 2.5 h the BNP level still remains signifi cantly reduced. Considering the half-life of BNP to be 23 min [14] , BNP-level should have returned to baseline if the apheresis would have eliminated the BNP-peptide. Furthermore, the highly selective apheresis with binding of the apoB, should not cause elimination of other proteins.
The recurrence of paroxysmal atrial fi brillation is related with increased levels of BNP [19] . Therefore, the demonstrated effect of blood viscosity on cardiac hemodynamics in our study is consistent with the fi nding that occurrence of post-operative atrial fi brillation after cardiac surgery is correlated with the amount of blood transfusion [20] . Not a linear but a logarithmic relationship exists between blood viscosity and the hematocrit [21] ; this is again especially true at low shear rate. Besides hematocrit infl ammatory proteins, especially fi brinogen and CRP, increase blood viscosity; the BNP level in our patients changed, whereas the hematocrit remained con- 
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